Authors: A Castello, A Goldhirsch, A Malin, AM Fair, B Lauby-Secretan, BA Simone, EH Allott, FF Zhang, GA Bray, J Vioque, M Harvie, M Kyrgiou, M Puig-Vives, MJ Dirx, MN Harvie, MN Harvie, MP Cleary, NS Sabounchi, R Peiro-Perez, RJ Elands, SA Silvera, SC Chang, SC Lucan, SD Hursting, SD Hursting, SW Lichtman, SY Pan, T Byers, V Lope, VD Longo, WC Willett
Published: January 1, 2019
In a multicenter matched case-control study of 973 case-control pairs of Spanish women (EPIGEICAM), premenopausal women consuming more than 20% below their predicted caloric needs had significantly lower breast cancer risk (OR = 0.36; 95% CI = 0.21–0.63). A clear dose-response relationship emerged: for every 20% increase in relative caloric intake (observed/predicted), risk of hormone receptor positive and HER2+ tumours increased by 13% (p-trend < 0.001 and p-trend = 0.015, respectively), while triple negative tumour risk increased by 7% per 20% increment.
